M1 KLINIKEN AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.25 EUR | +3.17% |
|
+18.68% | +44.64% |
| Feb. 05 | M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares | MT |
| 2023 | M1 Kliniken Takes Ownership of Dutch Online Pharmacy | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 262.5 | 250.2 | 181.5 | 139.3 | 168.3 | 288.5 | 288.5 | - |
| Enterprise Value (EV) 1 | 236.3 | 241.2 | 174.9 | 95.11 | 146.9 | 273.9 | 266.7 | 264.7 |
| P/E ratio | 38.5 x | 25.5 x | 25 x | 16.7 x | 41.2 x | 39.4 x | 27.4 x | 20.6 x |
| Yield | 2% | 2.1% | - | - | - | - | - | - |
| Capitalization / Revenue | 4.03 x | 3.24 x | 1.14 x | 0.44 x | 0.59 x | 0.93 x | 0.85 x | 0.78 x |
| EV / Revenue | 3.62 x | 3.12 x | 1.1 x | 0.3 x | 0.51 x | 0.88 x | 0.78 x | 0.72 x |
| EV / EBITDA | 33 x | 21.3 x | 19.7 x | 5.34 x | 9.53 x | 12.3 x | 9.67 x | 7.7 x |
| EV / FCF | 309 x | -35.9 x | 21.6 x | 6.63 x | 7.49 x | 101 x | 42.3 x | 17 x |
| FCF Yield | 0.32% | -2.78% | 4.63% | 15.1% | 13.3% | 0.99% | 2.36% | 5.89% |
| Price to Book | 3.96 x | 3.69 x | 2 x | 1.47 x | 1.24 x | 3.28 x | 2.67 x | 2.37 x |
| Nbr of stocks (in thousands) | 17,500 | 17,500 | 19,643 | 18,580 | 18,580 | 18,315 | 18,315 | - |
| Reference price 2 | 15.00 | 14.30 | 9.240 | 7.500 | 9.060 | 15.75 | 15.75 | 15.75 |
| Announcement Date | 7/12/19 | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 65.21 | 77.22 | 159.6 | 314.6 | 285.3 | 310.2 | 339.8 | 367.6 |
| EBITDA 1 | 7.171 | 11.33 | 8.889 | 17.82 | 15.41 | 22.21 | 27.58 | 34.36 |
| EBIT 1 | 6.46 | 7.932 | 4.405 | 12.13 | 9.348 | 15.48 | 20.19 | 26.49 |
| Operating Margin | 9.91% | 10.27% | 2.76% | 3.86% | 3.28% | 4.99% | 5.94% | 7.21% |
| Earnings before Tax (EBT) 1 | 8.095 | 12.74 | 8.777 | 14.42 | 10.23 | 15.61 | 20.45 | 26.75 |
| Net income 1 | 6.613 | 9.729 | 6.823 | 8.905 | 4.317 | 7.771 | 11.15 | 14.82 |
| Net margin | 10.14% | 12.6% | 4.28% | 2.83% | 1.51% | 2.51% | 3.28% | 4.03% |
| EPS 2 | 0.3900 | 0.5600 | 0.3700 | 0.4500 | 0.2200 | 0.4000 | 0.5750 | 0.7650 |
| Free Cash Flow 1 | 0.7645 | -6.716 | 8.094 | 14.35 | 19.61 | 2.7 | 6.3 | 15.6 |
| FCF margin | 1.17% | -8.7% | 5.07% | 4.56% | 6.87% | 0.87% | 1.85% | 4.24% |
| FCF Conversion (EBITDA) | 10.66% | - | 91.06% | 80.51% | 127.23% | 12.16% | 22.84% | 45.4% |
| FCF Conversion (Net income) | 11.56% | - | 118.63% | 161.14% | 454.12% | 34.74% | 56.48% | 105.23% |
| Dividend per Share 2 | 0.3000 | 0.3000 | - | - | - | - | - | - |
| Announcement Date | 7/12/19 | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2023 Q1 | 2023 S1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 29.13 | 130.5 | 63.5 | 75.17 | 138.7 | 76.8 | - |
| EBITDA | - | 5.943 | - | 3.161 | 7.361 | - | 9.947 |
| EBIT | - | 3.162 | - | 1.672 | 4.472 | - | - |
| Operating Margin | - | 2.42% | - | 2.22% | 3.23% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | - | 4.786 | - | - | - | - | - |
| Net margin | - | 3.67% | - | - | - | - | - |
| EPS | 0.1200 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/26/20 | 5/27/21 | 7/7/22 | 10/7/22 | 10/7/22 | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 26.2 | 9.01 | 6.6 | 44.2 | 21.4 | 14.6 | 21.8 | 23.8 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 0.76 | -6.72 | 8.09 | 14.3 | 19.6 | 2.7 | 6.3 | 15.6 |
| ROE (net income / shareholders' equity) | 11.9% | 14.8% | 8.86% | 9.85% | 3.05% | 8.2% | 9.75% | 11.6% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 3.790 | 3.870 | 4.620 | 5.110 | 7.280 | 4.800 | 5.900 | 6.650 |
| Cash Flow per Share | - | -0.3100 | 0.5100 | - | - | - | - | - |
| Capex 1 | 2.33 | 1.35 | 1.45 | 1.34 | 1.16 | 11.1 | 12.1 | 10.2 |
| Capex / Sales | 3.57% | 1.74% | 0.91% | 0.42% | 0.41% | 3.58% | 3.56% | 2.76% |
| Announcement Date | 7/12/19 | 5/27/20 | 5/27/21 | 5/20/22 | 6/13/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.75
EUR
Average target price
17.5
EUR
Spread / Average Target
+11.11%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +44.64% | 311M | |
| -18.46% | 16.57B | |
| +4.50% | 12.51B | |
| +4.31% | 11.69B | |
| +6.18% | 10.36B | |
| +24.72% | 8.38B | |
| -2.87% | 7.75B | |
| +19.32% | 7.12B | |
| +4.17% | 6.6B | |
| +46.90% | 4.54B |
- Stock Market
- Equities
- M12 Stock
- Financials M1 Kliniken AG